Association between androgen deprivation therapy and fracture risk: A population-based cohort study in men with non-metastatic prostate cancer

被引：0
|
作者：
Smith, MR
Lee, WC
Krupsi, T
Brandman, J
Wang, Q
Botteman, M
Pashos, C
Litwin, M
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] ABT Associates Inc, Bethesda, MD USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Nova Pharmaceut Corp, Florham Pk, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4507
引用
收藏
页码：383S / 383S
页数：1
相关论文
共 50 条
  • [31] The role of androgen deprivation therapy plus radiation therapy in patients with non-metastatic prostate cancer
    Zhao, Sherry
    Urdaneta, Alfredo I.
    Anscher, Mitchell S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 929 - 942
  • [32] Use of Intermittent Androgen Deprivation Therapy in Prostate Cancer: A Population-Based Study
    Tsai, Huei-Ting
    Penson, David
    Jiang, Miao
    Lynch, John H.
    Luta, George
    Potosky, Arnold L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 374 - 374
  • [33] Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation of standardized management guidelines
    Cheung, A. S.
    Pattison, D.
    Bretherton, I.
    Hoermann, R.
    Joon, D. Lim
    Ho, E.
    Jenkins, T.
    Hamilton, E. J.
    Bate, K.
    Chan, I.
    Zajac, J. D.
    Grossmann, M.
    ANDROLOGY, 2013, 1 (04) : 583 - 589
  • [34] Fracture risk assessment of men treated with androgen deprivation therapy for prostate cancer
    Turo, R.
    Smolski, M.
    Das, S.
    Awsare, N. S.
    Pettersson, B. A.
    Adeyoju, A.
    Bromage, S. J.
    Brown, S. C. W.
    Brough, R.
    Collins, G. N.
    BJU INTERNATIONAL, 2016, 118 : 29 - 29
  • [35] IS INTERMITTENT ANDROGEN DEPRIVATION THERAPY AN UNDERUTILIZED STRATEGY FOR MANAGEMENT OF RELAPSED, NON-METASTATIC, CASTRATION SENSITIVE PROSTATE CANCER? - A POPULATION-BASED ASSESSMENT OF A PROVINCIAL CANCER PROGRAM
    Janzen, Bryan
    Ong, Aldrich
    Bucher, Oliver
    Trozzo, Pat
    Penner, Makoy
    Koul, Rashmi
    Bashir, Bashir
    Dubey, Arbind
    Kim, Julian
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S16 - S17
  • [36] Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
    Crawley, Danielle
    Garmo, Hans
    Rudman, Sarah
    Stattin, Par
    Haggstrom, Christel
    Zethelius, Bjorn
    Holmberg, Lars
    Adolfsson, Jan
    Van Hemelrijck, Mieke
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (12) : 2698 - 2704
  • [37] Androgen deprivation therapy and the risk of iron-deficiency anaemia among patients with prostate cancer: a population-based cohort study
    Wu, Fang-Jen
    Li, I-Hsun
    Chien, Wu-Chien
    Shih, Jui-Hu
    Lin, Yi-Chun
    Chuang, Chin-Min
    Cheng, Yih-Dih
    Kao, Li-Ting
    BMJ OPEN, 2020, 10 (03):
  • [38] Subsequent risk of acute urinary retention and androgen deprivation therapy in patients with prostate cancer: A population-based retrospective cohort study
    Yang, Teng-Kai
    Wu, Chia-Chang
    Chang, Chao-Hsiang
    Muo, Chih-Hsin
    Huang, Chao-Yuan
    Chung, Chi-Jung
    MEDICINE, 2020, 99 (07)
  • [39] Statin use and mortality risk in Asian patients with prostate cancer receiving androgen deprivation therapy: A population-based cohort study
    Lee, Yan Hiu Athena
    Chan, Jeffrey Shi Kai
    Hui, Jeremy Man Ho
    Tang, Pias
    Liu, Kang
    Dee, Edward Christopher
    Ng, Kenrick
    Tse, Gary
    Ng, Chi Fai
    CANCER MEDICINE, 2024, 13 (01):
  • [40] The association between androgen deprivation therapy and pulmonary embolism: a population-based study
    Yii, S. -C.
    Chung, S. -D.
    Huang, C. -Y.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 36 - 37
12345